Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-55.63	5.21	11.74
Graham Fair Price	42.33	2.11	1.48
PEG	-67.16	0.04	-0.14
Price/Book	-2.48	0.31	0.32
Price/Cash Flow	-54.34	16.41	35.94
Prices/Earnings	-51.24	4.54	9.30
Price/Sales	-51.24	0.80	1.64
Price/FCF	-54.34	16.41	35.94
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.15	0.15
Operating Margin	202.30	< 0.005	< 0.005
ROA	100.00	0.01	< 0.005
ROE	< 0.005	0.02	100.00
ROIC	< 0.005	< 0.005	501.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.11	-0.22	-50.61
Dividends QOQ	-0.45	-0.40	11.88
EBIT QOQ	-0.92	-7.05	-669.28
EPS QOQ	-0.68	1.01	48.49
FCF QOQ	2.06	1.14	-45.00
Revenue QOQ	-0.50	1.00	100.16
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.37	35.68	-50.00
Days Sales Outstanding (DSO)	78.84	47.23	-40.09
Inventory Turnover	1.26	2.52	100.00
Debt/Capitalization	0.05	0.05	10.47
Quick Ratio	2.95	3.13	6.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3.35	3.37	0.64
Cash	1.23	1.24	0.64
Capex	-0.09	-0.19	-102.88
Free Cash Flow	0.03	0.06	114.95
Revenue	0.66	1.32	101.28
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	3.85	3.85	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-24.29	-10.78	55.63
Naive Interpretation	Member

06 - Financial Health · Bad

Rating